Cookies on PerkinElmer

PerkinElmer uses cookies to ensure that we give you the best experience possible on our website. This may include cookies from third party websites. If you continue without changing your settings, we will assume that you consent to receive cookies from this website. You can change your cookie settings at any time. To learn more, please review our cookie policy, which includes information on how to manage your cookies.

Life Sciences

From basic research and drug discovery to the development and manufacturing of new, significant drugs and clinical treatments, we are helping researchers accelerate the discovery-to-commercialization process, bringing better medicines to market faster. With a comprehensive portfolio from detection and imaging solutions to informatics and services, our forward-minded ideation to advance research possibilities have enabled many methods that once took weeks to perform to now be accomplished in a matter of hours.

Areas of Interest

Research, Drug Discovery & Development

Helping researchers and life science companies advance the discovery and development of drugs and therapeutics.

Learn More

Disease Research

PerkinElmer’s portfolio provides disease researchers the tools that enable insights and interactions between cell types and organ systems that lead to breakthroughs in prevention, early detection and treatment of diseases.

Learn More

Pharma & BioPharma QA/QC

Good Manufacturing Practice (GMP) not only drives the QA/QC inside your company, but it also guides PerkinElmer’s development of the technologies, tools, and processes we build to assure you are meeting your regulatory obligations while you continuously manufacture a compliant product.

Learn More

Biologics

From discovery through manufacturing, harnessing large molecule drugs to create safe and effective therapies is complex and expensive. PerkinElmer enables scientists to develop and streamline their entire biologics workflow so they can overcome these challenges and bring consistent, high-quality, biological medicines to market faster.

Learn More

Stories

Reversing the damage of Multiple Sclerosis

Neuroscientists successfully isolated in a petri dish oligodendrocyte progenitor cells, which aid in protecting the central nervous system from MS…

What do Las Vegas and Drug Discovery Have in Common?

The odds of getting a drug to market are not much better than winning in Las Vegas. But recent developments in Big Data are changing the odds…

Saving Big Dollars at Big Pharma

Over the past decade, pharmaceutical companies have been looking for ways to become more nimble, productive and cost-efficient. At one big company, part of that process was changing how…

Supporting Your Journey

Developing new medicines is a long and complex journey that starts with understanding the biology of a disease and then treating it. We understand those challenges and support you throughout your journey.